Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”
Meg J. Spriggs, Hannah Douglass, Rebecca J. Park, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders
Hubertus Himmerich, Yael Doreen Lewis, Chiara Conti, et al.
The World Journal of Biological Psychiatry (2023) Vol. 24, Iss. 8, pp. 643-706
Open Access | Times Cited: 58
From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)
Richard J. Zeifman, Meg J. Spriggs, Hannes Kettner, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Canalization and plasticity in psychopathology
Robin Carhart‐Harris, Shamil Chandaria, David Erritzøe, et al.
Neuropharmacology (2022) Vol. 226, pp. 109398-109398
Open Access | Times Cited: 66
Psychedelics therapeutics: What we know, what we think, and what we need to research
David Nutt, Meg J. Spriggs, David Erritzøe
Neuropharmacology (2022) Vol. 223, pp. 109257-109257
Open Access | Times Cited: 64
The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
Andrea Mastinu, Margrate Anyanwu, Marinella Carone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1329-1329
Open Access | Times Cited: 35
Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32
How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change
Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson, et al.
Journal of Affective Disorders (2023) Vol. 334, pp. 100-112
Open Access | Times Cited: 29
Exploring mechanisms of psychedelic action using neuroimaging
David Erritzøe, Christopher Timmermann, Kate Godfrey, et al.
Nature Mental Health (2024) Vol. 2, Iss. 2, pp. 141-153
Closed Access | Times Cited: 11
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 50
Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms
Abigail E. Calder, Seline Mock, Nicole Friedli, et al.
European Neuropsychopharmacology (2023) Vol. 75, pp. 1-14
Open Access | Times Cited: 18
Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review
Oliver Rumle Hovmand, Emil Deleuran Poulsen, Sidse Arnfred, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 649-659
Open Access | Times Cited: 16
Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice
Nicole Fadahunsi, Jens Lund, Alberte Wollesen Breum, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions
Anya Ragnhildstveit, Matthew Slayton, Laura Jackson, et al.
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 382-382
Open Access | Times Cited: 22
Psychedelic treatments for mental health conditions pose challenges for informed consent
Carolina Seybert, Gonçalo Cotovio, Luís Madeira, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2167-2170
Closed Access | Times Cited: 15
Neuroimaging in psychedelic drug development: past, present, and future
Matthew B. Wall, Rebecca Harding, Rayyan Zafar, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3573-3580
Open Access | Times Cited: 15
Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties
Mazen A. Atiq, Matthew Baker, Jennifer L. Vande Voort, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 4
Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review
I. Erkizia-Santamaría, Igor Horrillo, J. Javier Meana, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111249-111249
Closed Access
Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
Nadine Loh, David Luke
Psychoactives (2025) Vol. 4, Iss. 1, pp. 7-7
Open Access
Psychopharmacologic Management of Eating Disorders
Alexandra F. Muratore, Evelyn Attia
Current Psychiatry Reports (2022) Vol. 24, Iss. 7, pp. 345-351
Open Access | Times Cited: 21
Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder
Nicole Ledwos, Justyne D. Rodas, M. Ishrat Husain, et al.
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 3-13
Open Access | Times Cited: 17
Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis
John R. Kelly, Gerard Clarke, Andrew Harkin, et al.
International Journal of Clinical and Health Psychology (2022) Vol. 23, Iss. 2, pp. 100349-100349
Open Access | Times Cited: 16
Psychedelics and disorders of consciousness: the current landscape and the path forward
Paolo Cardone, Naji Alnagger, Jitka Annen, et al.
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 3
Current approaches in the recognition and management of eating disorders
Phillipa Hay, Rebekah Rankin, Lucie M. Ramjan, et al.
The Medical Journal of Australia (2023) Vol. 219, Iss. 3, pp. 127-134
Open Access | Times Cited: 8
Therapeutic frameworks in integration sessions in substance‐assisted psychotherapy: A systematised review
Sascha Thal, Paris Baker, Jonathon Marinis, et al.
Clinical Psychology & Psychotherapy (2023) Vol. 31, Iss. 1
Open Access | Times Cited: 8
Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review
Sascha Thal, Michelle Wieberneit, Jason M. Sharbanee, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 11, pp. 1191-1207
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top